A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
Padmanee Sharma, Marc-Oliver Grimm, Matthew D Galsky, Ari Baron, Sergio Bracarda, Arlene Siefker-Radtke, Alexandre Lambert, Alex Azrilevich, Margitta Retz
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P174; DOI: 10.1186/2051-1426-3-S2-P174
